Forcyl

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

marbofloxacin

Available from:

Vetoquinol New Zealand Limited

INN (International Name):

marbofloxacin

Composition:

marbofloxacin 160 g/litre

Therapeutic area:

Antibiotic

Authorization status:

ACVM Registered

Authorization date:

2016-02-17

Summary of Product characteristics

Forcyl
4 April 2022
ACVM A011142
Page 1 of 6
Bottle Label
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Forcyl
Solution for Injection
160 MG/ML MARBOFLOXACIN
Therapeutic treatment of respiratory infections in cattle caused by
sensitive strains of _Pasteurella _
_multocida_ and _Mannheimia haemolytica_.
Treatment of acute mastitis caused by sensitive strains of
_Escherichia coli_.
50 mL
READ THE ENCLOSED LEAFLET FOR FULL INSTRUCTIONS.
DIRECTIONS FOR USE
DISCARD UNUSED PORTION WITHIN 28 DAYS AFTER FIRST BROACHING.
The recommended dose is 10 mg/kg (10 mL/160 kg bw) by intravenous or
intramuscular injection
into the neck of cattle. Do not exceed 20 mL per intramuscular
injection site.
IT IS AN OFFENCE FOR USERS OF THIS PRODUCT TO CAUSE RESIDUES EXCEEDING
THE RELEVANT MRL IN THE FOOD
NOTICE: MAXIMUM RESIDUE LEVELS FOR AGRICULTURAL COMPOUNDS.
WITHHOLDING PERIOD
MEAT: CATTLE 5 DAYS
MILK: CATTLE 8 MILKINGS (96 HOURS)
STORAGE
Store below 25⁰C (air conditioning).
Discard unused portion within 28 days after opening.
RESTRICTED VETERINARY MEDICINE
Registered pursuant to the ACVM Act 1997, No. A011142
See www.foodsafety.govt.nz
for registration conditions.
Registered to
Vetoquinol New Zealand Limited
Phone: [phone]
Made in France
Batch No.:
Expiry Date:
Forcyl
4 April 2022
ACVM A011142
Page 2 of 6
CARTON LABEL
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Forcyl
Solution for Injection
160 MG/ML MARBOFLOXACIN
50 mL
(Vetoquinol logo)
SIDE PANEL
Therapeutic treatment of respiratory infections in cattle caused by
sensitive strains of _Pasteurella _
_multocida_ and _Mannheimia haemolytica_.
Treatment of acute mastitis caused by sensitive strains of
_Escherichia coli_.
READ THE ENCLOSED LEAFLET FOR FULL INSTRUCTIONS.
DIRECTIONS FOR USE
PRECAUTION
Indiscriminate use of the product could contribute to the development
of antibiotic resistance. The
product should only be used in individual cases of serious infections
that are not likely to respond